A provider of contract laboratory services and manufacturer of scientific instruments in the US, has opened a new European laboratory and office in Warwickshire, UK.
BASi, a provider of contract laboratory services and manufacturer of scientific instruments in the US, has opened a new European laboratory and office in Warwickshire, UK. The relocation to an upgraded facility with significantly expanded laboratories is expected to provide clients with enhanced capabilities throughout Europe.
The facility is reported to offer a comprehensive bioanalytical capability, as well as providing access to the company’s full range of preclinical and pharmaceutical analysis services for pharmaceutical and biotechnology companies.
"BASi Europe offers over a thousand established and validated analytical methods and procedures," said Mark Wareing, managing director of the European branch of the company. "We currently have multiple industry standard LC–MS–MS stations, as well as LC–EC and other analytical technologies, and we have invested in two more high-sensitivity MS–MS instruments with state-of-the-art front-end analytical systems."
For more information visit www.basinc.com
Advancing Bladder Cancer Research with Mass Spectrometry: A FeMS Interview with Marta Relvas-Santos
November 12th 2024LCGC International interviewed FeMS Empowerment Award winner Marta Relvas-Santos on her use of mass spectrometry to identify potential biomarkers and therapies for bladder cancer. She also shared insights on her work with FeMS and advice for fellow scientists.
Pharmaceutical excipients, such as polyethylene glycol-based polymers, must be tested for the presence of ethylene oxide (EtO) and 1,4-dioxane as part of a safety assessment, according to USP Chapter <228>.